YH-010

N/A

Report date: 2023/01/07 20:44:15

Base Information

Drug NameYH-010
Drug Alias NameYH010 (PD-L1 x IL-12全人抗体-细胞因子融合蛋白)YH-010
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionProgrammed death-ligand 1 blockersInterleukin-12 stimulants
TargetsProgrammed death-ligand 1Interleukin-12
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEucure Pharmaceutical Technology (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiocytogen Pharmaceuticals (Beijing) Co LtdEucure Pharmaceutical Technology (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A